CRVO
CRVO
NASDAQ · Biotechnology

Cervomed Inc

$2.67
+0.13 (+5.12%)
As of Sep 28, 10:29 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +1,251.3% upside
Low Target $23.71
Average Target $36.08
High Target $52.26
Current Price $2.67
Current
$2.67
Target
$36.08
$23.71 $36.08 avg $52.26
Scenario Analysis
Bear Case
$23.71
788.0%
Low target
Base Case
$36.08
+1,251.3%
Avg target
Bull Case
$52.26
+1,857.3%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$10.00
-73.3% from high
52-Week Low
$2.13
+25.4% from low
Target vs 52W High
$36.08
+260.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%